Publication
April 8, 2024
Validation of a Novel Type II HER2 Inhibitor Through Preclinical Studies Across Various Cancer Models (AACR 2024 Poster)
Related articles
Publication
September 21, 2026
AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery
Read more
Publication
June 22, 2026
Bayer and Iambic collaborate to advance drug discovery with AI
Read more
Publication
May 19, 2026
Iambic Named to CNBC Disruptor 50 for Second Consecutive Year
Read more
View more
Let's work together
Leverage the Iambic discovery process for your program. Reach out to us at partnerships@iambic.ai.
Contact us
Better technology for better medicines
GET IN TOUCH
contact@iambic.ai
(619) 330-5499
COMPANY
AboutNews & MediaCareersContact
TECHNOLOGY
PlatformPipelinePartners
Privacy Policy
Terms of Service
Copyright © 2026 Iambic Therapeutics, Inc. All Rights Reserved.